PBS News Hour - Science podcast

High cost of GLP-1s drives some to seek cheaper, unregulated versions

0:00
8:49
Manda indietro di 15 secondi
Manda avanti di 15 secondi
Despite some recent improvements, millions of Americans still face significant barriers in affording GLP-1s. At the same time, many patients have found alternative, cheaper paths to get their hands on unregulated versions. Stephanie Sy reports for our series, GLP-1s: Reshaping America. PBS News is supported by - https://www.pbs.org/newshour/about/funders. Hosted on Acast. See acast.com/privacy

Altri episodi di "PBS News Hour - Science"